Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
Clinical trial NCT00291057 · TERMINATED
Trial details
- NCT number
- NCT00291057
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2006-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.